Coexistence of bullous pemphigoid with neuropsychiatric comorbidities is associated with anti‐BP230 seropositivity

Authors: Ständer, S., Hammers, C.M., Vorobyev, A., Schmidt, E., Hundt, J.E., Sadik, C.D., Lange, T., Zillikens, D., Ludwig, R.J., Kridin, K.

Source: Journal of the European Academy of Dermatology and Venereology. 35(10):2067-2073

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100130136971.0x000001&indx=1&recIds=ETOCvdc_100130136971.0x000001

Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180‐NC16A‐specific IgG antibodies in bullous pemphigoid

Authors: Emtenani, S., Yuan, H., Lin, C., Pan, M., Hundt, J.E., Schmidt, E., Komorowski, L., Stanley, J.R., Hammers, C.M.

Source: British journal of dermatology. 180(5):1099-1106

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100084042432.0x000001&indx=1&recIds=ETOCvdc_100084042432.0x000001

LB1644 Transcriptome analysis defines combinatory pathway activity in keratinocytes necessary for split formation in pemphigus vulgaris

Authors: Radine, U., Burmester, I., Guo, S., Hariton, W.V., Rahimi, S., Hammers, C.M., Ludwig, R.J., Müller, E.J., Hundt, J.E., Busch, H.

Source: Journal of investigative dermatology. 143(9):B4-B4

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100195579473.0x000001&indx=1&recIds=ETOCvdc_100195579473.0x000001

LB1750 PC111, an anti-FasL neutralizing antibody, blocks pemphigus blister formation in in-vitro, ex-vivo and in-vivo human models

Authors: Lotti, R., Marconi, A., Amato, A., Bennett, B., Hundt, J.E., Hammers, C.M., Ludwig, R.J., Pincelli, C.

Source: Journal of investigative dermatology. 143(9):B26-B26

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100195579088.0x000001&indx=1&recIds=ETOCvdc_100195579088.0x000001

370 Role of proliferation and mechanostructural signaling in pemphigus vulgaris

Authors: Rahimi, S., Hariton, W.V., Guo, S., Sauta, P., Borradori, L., Hartmann, V., Zare-Eelanjegh, E., Paccagnan, G., Zambelli, T., Hundt, J.E., Hammers, C.M., Ludwig, R.J., Busch, H., Mueller, E.J.

Source: Journal of investigative dermatology. 143(S):S63-S63

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187666127.0x000001&indx=1&recIds=ETOCvdc_100187666127.0x000001

016 PC111, a novel, First In Class, human anti-FasL antibody for the treatment of Pemphigus: a translational study

Authors: Lotti, R., Marconi, A., Hundt, J.E., Hammers, C.M., Amato, A., Bennett, B., Ludwig, R.J., Pincelli, C.

Source: Journal of investigative dermatology. 142(S):S183-S183

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185889551.0x000001&indx=1&recIds=ETOCvdc_100185889551.0x000001

620 Screening an inhibitor library for new drug candidates to promote wound healing

Authors: Jacobi, C., Göb, M., Huber, R., Ludwig, R.J., Hundt, J.E.

Source: Journal of investigative dermatology. 142(S):S288-S288

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100176270378.0x000001&indx=1&recIds=ETOCvdc_100176270378.0x000001

011 Targeted inhibition of complement C3 deposition at the basement membrane zone in pemphigoid disease

Authors: Hammers, C.M., Emtenani, S., Khodr El-Oueyk, A., Papara, C., Isken, O., Tautz, N., Lin, C., Hundt, J.E., Verschoor, A., Zillikens, D., Schmidt, E., Siegel, D.L., Stanley, J.R.

Source: Journal of investigative dermatology. 142(S):S182-S182

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100175720872.0x000001&indx=1&recIds=ETOCvdc_100175720872.0x000001

028 PC111, a monoclonal anti-Fas Ligand antibody, blocks blister formation in human pemphigus

Authors: Lotti, R., Marconi, A., Hundt, J.E., Hammers, C.M., Zagari, F., Camboni, M., Bennett, B., Ludwig, R.J., Pincelli, C.

Source: Journal of investigative dermatology. 141(S):S153-S153

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100144211929.0x000001&indx=1&recIds=ETOCvdc_100144211929.0x000001

Bullous pemphigoid autoantibody‐mediated complement fixation is abolished by the low‐molecular‐weight heparin tinzaparin sodium

Authors: Gutjahr, A., Heck, F., Emtenani, S., Hammers, A.‐K., Hundt, J.E., Muck, P., Siegel, D.L., Schmidt, E., Stanley, J.R., Zillikens, D., Hammers, C.M.

Source: British journal of dermatology. 181(3):593-594

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100087639950.0x000001&indx=1&recIds=ETOCvdc_100087639950.0x000001

050 Male mice have a higher epidermolysis bullosa acquisita disease score upon autoantibody transfer in the morning

Authors: Stenger, S., Pfündl, R., Stilla, T.R., Renje, J., Hartmann, V., Koch, C., Oster, H., Lange, T., Hundt, J.E.

Source: Journal of Investigative Dermatology; December 2024, Vol. 144 Issue: 12, Number 12 Supplement 1 pS237-S237, 1p

015 Interferon and tumour necrosis factor α are upregulated in the human skin organ culture model for pemphigus vulgaris as a secondary effect to split formation

Authors: Hartmann, V., Hariton, W.V., Rahimi, S., Guo, s., Hammers, C.M., Ludwig, R., Busch, H., Müller, E.J., Hundt, J.E.

Source: Journal of Investigative Dermatology; December 2024, Vol. 144 Issue: 12, Number 12 Supplement 1 pS231-S231, 1p

040 Pathogenicity of anti-desmoglein 3 IgA1 autoantibodies is Fc-dependent in IgA pemphigus

Authors: Emtenani, S., Johns, J., Recke, A., Komorowski, L., Probst, C., Hundt, J.E., Hashimoto, T., Zillikens, D., Schmidt, E., Ludwig, R., Hammers, C.M.

Source: Journal of investigative dermatology. 139(S):S221-S221

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100087923382.0x000001&indx=1&recIds=ETOCvdc_100087923382.0x000001

370 Anti-desmoglein 3 autoantibodies cloned from the IgA1 repertoire of an IgA pemphigus patient are directly pathogenic, but not sufficient for disease induction

Authors: Emtenani, S., Johns, J., Langenhan, J., Komorowski, L., Hundt, J.E., Schmidt, E., Zillikens, D., Ludwig, R.J., Hammers, C.M.

Source: Journal of investigative dermatology. 137(10):S256-S256

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100061700867.0x000001&indx=1&recIds=ETOCvdc_100061700867.0x000001

LB1750 PC111, an anti-FasL neutralizing antibody, blocks pemphigus blister formation in in-vitro, ex-vivoand in-vivohuman models

Authors: Lotti, R., Marconi, A., Amato, A., Bennett, B., Hundt, J.E., Hammers, C.M., Ludwig, R.J., Pincelli, C.

Source: Journal of Investigative Dermatology; September 2023, Vol. 143 Issue: 9 pB26-B26, 1p